Junji Wada
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Mitsuo Katano (14 shared papers)Masao Tanaka (10 shared papers)Shuntaro Nagai (10 shared papers)Akio Yamasaki (7 shared papers)Takashi Morisaki (8 shared papers)Hideya Onishi (5 shared papers)Kosuke Yanai (6 shared papers)Hiroyuki Y. Suzuki (4 shared papers)
- Journals
- Journal of Surgical Oncology (2 papers)Immunological Investigations (1 paper)Cancer Science (1 paper)European Journal of Immunology (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Junji Wada
16 papers receiving 982 citations
Peers
Comparison fields: 5 of 80
- Immunology 335
- Oncology 404
- Cancer Research 140
- Molecular Biology 449
- Pathology and Forensic Medicine 64
Countries citing papers authored by Junji Wada
This map shows the geographic impact of Junji Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Wada more than expected).
Fields of papers citing papers by Junji Wada
This network shows the impact of papers produced by Junji Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Wada. The network helps show where Junji Wada may publish in the future.
Co-authors
The 25 scholars most cited alongside Junji Wada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 155 | |
| 2 | 2009 | 153 | |
| 3 | The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions. | 2009 | 142 |
| 4 | 2009 | 110 | |
| 5 | 2007 | 77 | |
| 6 | Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions. | 2010 | 68 |
| 7 | 2008 | 58 | |
| 8 | 2008 | 57 | |
| 9 | 2006 | 56 | |
| 10 | Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells. | 2009 | 55 |
| 11 | Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. | 2009 | 24 |
| 12 | Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. | 2008 | 22 |
| 13 | A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. | 2009 | 18 |
| 14 | 2002 | 4 | |
| 15 | 1979 | 3 | |
| 16 | 1984 | 2 | |
| 17 | 2004 | 0 |
About Junji Wada
Junji Wada is a scholar working on Immunology, Oncology, Molecular Biology, Cell Biology and Pharmacy, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers), Hedgehog Signaling Pathway Studies (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Meat and Animal Product Quality (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Immunology (335 citations), Oncology (404 citations), Cancer Research (140 citations), Molecular Biology (449 citations) and Pathology and Forensic Medicine (64 citations). Junji Wada has collaborated with scholars based in Japan and United States. Frequent co-authors include Mitsuo Katano, Masao Tanaka, Shuntaro Nagai, Akio Yamasaki, Takashi Morisaki, Hideya Onishi, Kosuke Yanai, Hiroyuki Y. Suzuki, Kenichiro Koga and Masafumi Nakamura. Their work appears in journals such as Journal of Surgical Oncology, Immunological Investigations, Cancer Science, European Journal of Immunology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.